Navigation Links
Anpath Group, Inc. Reports Progress in Japanese Market
Date:9/22/2009

MOORESVILLE, N.C., Sept. 22 /PRNewswire-FirstCall/ -- Anpath Group, Inc. (OTC Bulletin Board: ANPG), reported today that its wholly-owned subsidiary, EnviroSystems, Inc. (ESI) has made steady progress in the Japanese market through its collaboration and distribution agreement with Minntech Japan. Minntech Japan is a division of Minntech Corporation, ESI's manufacturing partner.

Anpath announced the Minntech Japan relationship in November 2008 and has since reported the joint strategy to penetrate the Japan healthcare market. Minntech Japan intends to expand its current dialysis focus and has plans to introduce EnviroTru(R) Disinfectant & Deodorizing Cleaner at several influential facilities and professional meetings during the near future. Mr. Mike Kitamura, Managing Director, Minntech Japan Corporation, provided examples of the expansion effort. "We are honored to present EnviroTru(R) to the Okinawa-Daiichi Hospital where EnviroTru(R) will be considered as a control agent for potential pandemic. In addition, EnviroTru(R) will be introduced and displayed at the Japanese Society of Blood Purification in Critical Care, the Japanese Society of Hemodiafiltration (HDF) Therapy meeting and the Kyushu Society of Hemodiafiltration (HDF) meeting."

J. Lloyd Breedlove, Anpath Group, Inc, President & CEO stated, "Our relationship with Minntech continues to be positive for our company on multiple levels. We are very pleased with the success to date in Japan. Mr. Kitamura and his staff continue to make good progress in what is a large progressive healthcare market in Japan."

EnviroTru(R) is a multi-purpose disinfectant, sanitizer and deodorizing cleaner effective against numerous organisms, including MRSA. EnviroTru(R) is registered by the Environmental Protection Agency (EPA) and meets requirements for Toxicity Category IV (minimal effects noted, no precautionary or first aid statements required; no harmful dermal, ocular, inhalation or ingestion effects), which is the lowest toxicity level available on the market today. EnviroTru(R) does not require protective clothing, gloves or special ventilation.

About Anpath Group, Incorporated:

Anpath Group, Inc. (Anpath), through its wholly-owned subsidiary EnviroSystems, Inc., produces cleaning and disinfecting products that it believes will help prevent the spread of infectious microorganisms while minimizing the harmful effects to people, equipment or the environment. Visit www.anpathgroup.com for more information.

EnviroSystems, Inc. is focused on safe infection prevention technologies that the company believes will position the company in the forefront of the industry at a time when there is rapidly growing awareness of the critical need to prevent biological risks -- both natural and man-made. Visit www.envirosi.com for more information.

Forward Looking Statements:

This release may contain forward-looking statements, which reflect expectation or belief by Anpath Group, Inc. concerning future events that involve risks and uncertainties. Anpath Group can give no assurance that the expectations reflected in forward looking statements will prove correct and various factors could cause results to differ materially from Anpath Group expectations, including, but not limited to U.S. EPA and state registration of Anpath Group's products, foreign registration of its products, its ability to carry out its business plan, successful development and commercial acceptance of its products, ability to fund development of its technology, the risk that products may not result from development activities, protection of its intellectual property, need for regulatory approvals, and other factors discussed in periodic Anpath Group, Inc. filings with the Securities and Exchange Commission. Forward-looking statements are qualified in their entirety by the above cautionary statement. Anpath Group assumes no duty to update its outlook or other forward-looking statements as of any future date.


'/>"/>
SOURCE Anpath Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win;
2. Burnham Institute for Medical Research and Magellan BioScience Group, Inc. Announce Drug Discovery Collaboration
3. Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
4. Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.
5. Bio-Matrix Scientific Group, Inc. Gets Updated Stock Recommendation By KonLin Investment Letter
6. Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016
7. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
8. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
9. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
10. Stem Cell Sciences Enters into Services Agreement with Huntingdons Disease Research Group, CHDI Foundation Inc.
11. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2017)... Basel, Switzerland (PRWEB) , ... July 18, 2017 ... ... for R&D, today announced that Merck, a leading science and technology company, has ... develop innovative therapeutics for the therapeutic areas of Oncology, Immunology, and Neurodegenerative Diseases. ...
(Date:7/18/2017)... ... July 18, 2017 , ... Allotrope ... released the first phase of the Allotrope Framework for commercial use. , The ... created to “not only elevate the critical role of information technology in modern ...
(Date:7/17/2017)... ... July 17, 2017 , ... The Academy of Model ... of National Model Aviation Day will take place from 9 a.m. to 2 p.m. ... include activities for all ages. , Aviation Adventure Day will be packed with entertaining ...
(Date:7/17/2017)... ... July 17, 2017 , ... Neurodevelopmental disorders (NDDs) ... of overlapping clinical features. The advancement of targeted next-generation sequencing (NGS) has been ... and testing. , However, designing a custom panel for disease research requires ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):